Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2% 
- Check32 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0SummaryDifference0.0% 
- Check47 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no other substantive content changes.SummaryDifference0.1% 
- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1% 
- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as the introduction of new pharmacological terms related to breast cancer treatment. Notably, the revision number has been updated to v3.0.0.SummaryDifference6% 
- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0% 
Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.